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Abstract. 26 
 A considerable proportion of dietary plant-polyphenols reach the colon intact; determining 27 
the effects of these compounds on colon-health is of interest. We hypothesise that both fibre 28 
and plant polyphenols present in açai (Euterpe oleracea) provide prebiotic and anti-genotoxic 29 
benefits in the colon.  We investigated this hypothesis using a simulated in vitro gastrointestinal 30 
digestion of açai pulp, and a subsequent pH-controlled, anaerobic, batch-culture fermentation 31 
model reflective of the distal region of the human large intestine.  32 
Following in vitro digestion, 49.8% of the total initial polyphenols were available. In mixed-33 
culture fermentations with faecal inoculate, the digested açai pulp precipitated reductions in 34 
the numbers of both the Bacteroides-Prevotella spp. and the Clostridium-histolyticum 35 
groups, and increased the short-chain fatty acids produced compared to the negative control. 36 
The samples retained significant anti-oxidant and anti-genotoxic potential through digestion 37 
and fermentation.  38 
Dietary intervention studies are needed to prove that consuming açai is beneficial to gut 39 
health.  40 
  41 
 42 
Keywords: Açai pulp, Simulated in vitro digestion, Gut microbiota, DNA genotoxicity, 43 
Phenolic compounds. 44 
 45 
 46 
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1   Introduction 52 
A high intake of fruit and vegetables reduces the risk of age related disease (Arts & Hollman, 53 
2005). Mechanistic studies suggest that these effects may be mediated, in part, by the 54 
interaction of undigested plant foods, and not limited to the traditional definitions of dietary 55 
fibre, with the gut microbiota (Marchesi et al., 2016). The prebiotic and health promoting 56 
influences of the plant polyphenols in the colon are of current interest (Williamson & 57 
Clifford, 2010).  58 
Açai is an anthocyanin rich Amazonian food with putative benefits to health (Heinrich, 59 
Dhanji, & Casselman, 2011). Intact, the polyphenols present in açai and other polyphenol rich 60 
plant foods may protect against oxidative genotoxic damage, however residual anti-genotoxic 61 
effects through the gut will be dependent on how well the phenolics survive the digestion 62 
process. Ileostomy studies show that polyphenols are not efficiently absorbed in the small 63 
intestine and up to 40 % of those consumed may reach the colon where they are subject to 64 
degradation by the gut microbiota (Tzounis et al., 2011). The products of polyphenol 65 
breakdown are low molecular weight phenolics, such as caffeic acid, which may themselves 66 
have beneficial bioactive effects (Williamson & Clifford, 2010). Estimates of total polyphenol 67 
intake in Europe suggest levels of consumption exceed 1g per day; a better understanding of 68 
the effects of polyphenol rich foods in the gut is therefore desirable (Saura-Calixto, Serrano, 69 
& Goñi, 2007).    70 
With a high lipid (~49%) content, açai is a relatively energy dense fruit (Heinrich et al., 71 
2011). The lipids present are oleic acid (~56.2%), palmitic acid (~24.1%) and linoleic acid 72 
(~12.5%) (Del Pozo-Insfran, Brenes, & Talcott, 2004). Compositionally, açai is also rich in 73 
insoluble fibre with a smaller fraction of soluble fibre (Schauss et al., 2006, Yamaguchi et al., 74 
2015), it contains ~52.2g/100g DW carbohydrates (Del Pozo-Insfran et al., 2004) and an 75 
abundance of polyphenols in the form of flavonoids and anthocyanins (Gordon et al., 2012). It 76 
is assumed that the lipids and non-fibre carbohydrates are absorbed in the small intestine and 77 
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that the fibre and a significant fraction of the phenolics survive digestion and may serve as 78 
microbial substrates in the colon.     79 
This study aimed to elucidate the probable effects of digested açai on the colonic microbiota 80 
using a model of the digestive process, involving a simulated oral, gastric and then small 81 
intestinal digestion, the removal of small molecules via dialysis, and finally a simulated 82 
colonic fermentation in a pH-controlled, stirred, batch-culture system, with human faecal 83 
innocula, reflecting of the environmental conditions of the distal region of the human large 84 
intestine (Guergoletto, Costabile, Flores, Garcia, & Gibson, 2016). Our primary outcome 85 
measures are induced changes in bacterial groups at the genus level, as measured by 86 
fluorescent in situ hybridisation, and changes in short chain fatty acid concentrations. As a 87 
secondary outcome measure, the fates of the polyphenols present in the acai, through each 88 
stage of the process have been followed, along with the anti-genotoxic activity of the 89 
fermentation supernatants produced against a cultured colonic cell line.  90 
 91 
 92 
 93 
 94 
 95 
 96 
 97 
 98 
 99 
 100 
 101 
 102 
 103 
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2 Materials and Methods 104 
2.1   Chemicals. 105 
Agarose, EDTA, trizma base, triton, hydrogen peroxide (H2O2), HEPES, and ethidium 106 
bromide were purchased from Sigma-Aldrich Ltd. (Dorset, UK). Sodium chloride (NaCl) 107 
and potassium chloride (KCl) were supplied from Fisher Scientific (Loughborough, UK). 108 
Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum 109 
(FBS), 2mM L-glutamine, 100 IU/ml penicillin/streptomycin  were obtained from Lonza, 110 
(UK). Phenolic acids standards were obtained from Sigma-Aldrich (UK) and anthocyanin 111 
standards were purchased from Extrasynthese (Genay, France) for HPLC analysis. Other 112 
chemicals and reagents used in this study were obtained from either Sigma Aldrich 113 
(Poole, Dorset, UK) or Fisher Scientific (Loughborough, UK). 114 
2.2 Açai fruit pulp. 115 
Pure açai pulp was harvested from fully ripe fruits in 2013 and was kindly supplied by 116 
Sublime foods (UK). Samples were prepared as described previously (Mills et al., 2008). 117 
In brief, açai pulp (100 g) was freeze-dried upon receipt. The sample was frozen overnight 118 
at −80°C and then dried in an IEC Lyoprep-3000 freeze dryer (Dunstable, UK) for one 119 
week before the samples were ground to powder. Freeze-dried açai was stored at -20°C 120 
until use. 121 
2.3 Simulated in vitro intestinal digestion. 122 
A simulated digestion of freeze-dried açai was conducted to look at the potential 123 
bioavailability and bioactivity of açai polyphenols. The digestion followed the protocol 124 
described by Maccaferri et al. (Maccaferri et al., 2012). The remaining digesta was 125 
transferred into a sealed 1 KDa cellulose dialysis membrane (Cheshire biotech Cheshire, 126 
UK,) and dialysed against NaCl (0.01 M, 4 °C) to remove low molecular mass digestion 127 
products and monosaccharides.  After 15 hours, the dialysis fluid was changed and dialysis 128 
then continued for a further 2 h. 1 ml aliquots were sampled from the fluids either side of 129 
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the dialysis membrane, representing the small molecules likely absorbed in the small 130 
intestine and the digesta retained which might then pass to the colon. The retained digesta 131 
was freeze dried (~5days) (Christ- Gamma 2-16 LSC-Germany) in preparation for a 132 
simulated in vitro fermentation.133 
2.4 In Vitro Batch Culture Fermentation 134 
The anaerobic batch culture system has been described previously (Ramnani et al., 2012). 135 
Briefly, vessels (working volume 300 mL) were filled with 135 mL of sterile basal nutrient 136 
medium [peptone water (2 g/L), yeast extract (2 g/L), NaCl (0.1 g/L), K2HPO4 (0.04 g/L), 137 
KH2PO4 (0.04 g/L), MgSO4.7H2O (0.01 g/L), CaCl2.6H2O (0.01 g/L), NaHCO3 (2 g/L), 138 
Tween 80 (2 ml/L), Haemin (0.05 g/L), vitamin K1  (10 ml/L), L-cysteine (0.5 g/L), bile 139 
salts (0.5 g/L), resazurin (1 mg/L) and distilled water (Sigma Aldrich, UK)]. These vessels 140 
were gassed overnight with O2-free N2 at a rate of 15 ml/min. The temperature of the basal 141 
nutrient medium was set to 37 °C by use of a circulating water bath and the pH was 142 
maintained at 6.8 using a pH controller and NaOH 1M and acidic HCl 1M as necessary 143 
(Electrolab, UK). In order to mimic conditions located in the distal region of the human large 144 
intestine the experiment was run under anaerobic conditions, 37 °C and pH 6.8− 7.0 for a 145 
period of 24 h.  146 
Faecal samples were collected from three separate individuals and used as inoculant for the 147 
simulated colonic fermentation of the digested açai. All donors were in good health and had 148 
not taken any antibiotics for at least 6 months before the study; they had no history of bowel or 149 
gastrointestinal diseases. Samples were donated on the morning of the fermentation. The 150 
volunteers were asked to provide these in an anaerobic jar (AnaerojarTM 2.5L, Oxoid Ltd) 151 
which included a gas-generating kit in order to maintain anaerobic conditions. Samples were 152 
diluted (1:10 W/V) with phosphate buffered saline (0.1 M; pH 7.2) and homogenised in a 153 
stomacher (Seward, Norfolk, UK) for 2 min at normal speed. Faecal slurries (15 ml) for each 154 
individual were introduced to three different batch-culture vessels. 1 gram of the freeze dried 155 
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simulated digesta from the process described above, or a preparation of digesta not 156 
containing açai  (as a negative control), was used as a substrate in the batch culture vessels. 157 
Fermentation was conducted for 24 h, and samples were collected at three time points (0, 8, 158 
and 24 hours) for analysis (Figure 22). Samples were stored at -20 °C until analysis. 159 
2.5 Identification and quantification of gastric and colonic metabolites. 160 
2.5.1 High-performance liquid chromatography (HPLC). 161 
Phenolic acids and other compounds present in fresh açai pulp, and the phenolics present in 162 
samples following the simulated digestion and following the batch culture simulated colonic 163 
fermentation were assessed via HPLC. Methanol extracts were prepared with samples at each 164 
stage of the digestion model. The extracts were centrifuged at 13,000 g for 10 min and the 165 
filtered through 0.45 µm-acrodisc filters to remove particulates. HPLC was performed using 166 
an Agilent 1100 series HPLC (Hewlett –Packard, Agilent, Bracknell, UK). A Nova Pak C18 167 
column (250 mm  4.6 mm ID, 5 µm particle size) (Waters Ltd, Elstree, UK) was used to 168 
separate the phenolic constituents. The solvent flow rate was 0.4 ml/min and the column was 169 
allowed to equilibrate for 15 min between each injection. Mobile phase A consisted of 95% 170 
HPLC water, 5% methanol and 0.1% HCl (5 M). Mobile phase B was 50% HPLC water, 50% 171 
acetonitrile and 0.1% HCl (5M). Phenolic compounds were characterised by their retention 172 
time and comparison with known phenolic standards (Rodriguez-Mateos, Cifuentes-Gomez, 173 
Tabatabaee, Lecras, & Spencer, 2012). Detection wavelengths were 280, 254, 320 and 520 174 
nm and all data was analysed using ChemStation software. A standard curve was used to 175 
quantify the amount of each compound. 176 
2.6 Total phenolic content. 177 
The total phenolic contents were analysed according to the Folin–Ciocalteu method 178 
adapted to 96-well plate microlitre assay, using gallic acid as the standard; 5 µl of the 179 
diluted extracts or standards were mixed with 145 µl of distilled water and 25 µl of Folin– 180 
Ciocalteu reagent (Sun, Chu, Wu, & Liu, 2002). After 3 min at room temperature, 100 µl 181 
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of saturated sodium carbonate solution was added and the solution kept in a shaker for 25 182 
min at room temperature. The absorbance of the samples were measured at 650 nm, using 183 
a GENios pro microplater reader (Tecan, Theale, Berks, UK) equipped with the Magellan 184 
Software system. Methanolic solutions of gallic acid (Sigma–Aldrich, Poole, Dorset, UK) 185 
with concentrations of 0–1000 mg/l were used for the calibration curve, and results were 186 
expressed as gallic acid equivalents (GAE) per mg/g of freeze-dried açai starting material 187 
(mean ± SD; n = 3, triplicate analysis). 188 
2.7 Antioxidant activity using the FRAP assay. 189 
The antioxidant activity of the açai extracts, and of extracts from digested acai, were 190 
determined using the FRAP assay, which is based on the ferric ion reducing power where 191 
the formation of a deep blue complex is readily discernible (Fe2+/TPTZ) (Benzie & 192 
Strain, 1996). Serial dilutions of ascorbic acid were prepared as a standard curve (0–193 
1000 µmol). 10 µL of solvent extract of samples, or standard, were added to wells of a 194 
96-well plate, followed by 300 µL of FRAP reagent (2.5 mL of 10 mmol/L TPTZ in 40 195 
mmol/L HCl solution and 2.5 ml of 20 mmol/L ferric chloride hexahydrate solution in 25 196 
mL of 0.3 M acetate buffer (pH 3.6)). After a 30 minute incubation, absorbance was 197 
measured at 600 nm using a  GENios  reader  at  room  temperature  with  MagellanTM   198 
software.  The antioxidant capacity was calculated relative to ascorbic acid standards and 199 
expressed as µM ascorbic acid equivalent/L. 200 
2.8  In vitro bacterial enumeration by fluorescence in situ hybridisation (FISH).  201 
FISH was performed as described by Daims et al. (Daims, Stoecker, & Wagner, 2005). 202 
Briefly, fermentation samples were taken from batch culture vessels at time points: 0, 8, and 203 
24 hours of incubation with digested açai. Oligonucleotide probes, designed to target 204 
specific regions of 16S rRNA, were commercially synthesized and labelled with the 205 
fluorescent dye, Cy3 (Sigma–Aldrich, UK). Bacterial groups enumerated were: Bif164 for 206 
Bifidobacterium spp. (Langendijk et al., 1995),  Lab158  for Lactobacillus/Enterococcus  207 
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spp.  (Harmsen, Elfferich, Schut, & Welling, 1999),  Bac303  for Bacteroides spp. (Manz, 208 
Amann, Ludwig, Vancanneyt, & Schleifer, 1996), Erec482 for Clostridium coccoides-209 
Eubacterium rectale group (Franks et al., 1998), Chis150 for Clostridium histolyticum 210 
group and EUB338 for total bacteria ( D a im s ,  Br ü h l ,  A m an n ,  S ch l e i f e r ,  & 211 
W agn er ,  1 99 9 ) .  212 
2.9   Short chain fatty acid analysis (SCFAs) 213 
Aliquots of batch culture samples were centrifuged at 13000g for 10 min, and the supernatant 214 
was then filtered through 0.45 µm-acrodisc filters to remove bacteria. 50 µL of supernatant 215 
was injected into the HPLC, with separation of SCFA achieved using an Aminex Ion 216 
Exclusion HPX-87H column (300 mm x 7.8 mm). (Mobile phase, 0.005 M H2SO4, flow rate 217 
0.6 ml/min, 65°C) with detection of SCFA at a wavelength of 215 nm. Calibration curves 218 
were prepared for acetic, propionic, N-butyric, Iso-butyric and formic acids, with 219 
concentrations between 1.25 mM and 30 mM. 220 
2.10  Cell culture 221 
The human HT29 colorectal adenocarcinoma cell line was used as a model for the intestinal 222 
tract.  Cells were obtained from the European collection of cell cultures (ECACC) (Salisbury, 223 
UK) and cultured in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10 % 224 
heat-inactivated fetal bovine serum (FBS), 2 mM L-glutamine,100 IU/ml 225 
penicillin/streptomycin. Phosphate Buffered Saline (PBS) and Trypsin- Versene (EDTA) 226 
were purchased from Lonza Ltd (Switzerland). Cells were passaged (21 to 35) twice a week in 227 
a T75 cm3 cell culture flask (Fisher scientific,UK) and the media was changed every 2 days. 228 
The cells were grown for 5-6 days (approximately 75% confluence) at 37 °C with 5 % CO2 229 
and 95% humidity. (Fisher Scientific,UK) (Coates et al., 2007).  230 
2.11  Cytotoxicity assay. 231 
HT29 cells were seeded in a 96-well micro-plate Thermo Fisher Scientific Inc, Roskilde, 232 
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Denmark) at a concentration of 1.6 x 105 (250µl) cells/ml and incubated for 24 hours at 37 233 
˚C prior to the assay.  Dilutions of filter sterilised fermented açai supernatants (0h and 24h) 234 
were prepared in carrier control (at 0%, 1%, 2.5%, 5%, 10% (v/v)) and incubated with cells 235 
for 24 hours at 37˚C. The medium was removed and 100 µL of 4′, 6-Diamidino-2 236 
phenylindole dihydrochloride (DAPI) (3mM) was added for 4h at 37˚C. The DAPI was 237 
removed and absorbance measured at 540 nm using a GENios ProTM micro-plate reader 238 
with MagellanTM. The experiment was repeated in triplicate in independent experiments. 239 
The results were expressed as mean % cell survival normalised to control (without 240 
treatment). 241 
2.12    Anti-genotoxicity assay, single cell Gel Electrophoresis (Comet assay). 242 
The assay was carried out following a method described  previously (Brown et al., 2012). 243 
HT29 cells were adjusted to 3.2x106  cells ml-1 (450µl). The cells were incubated with the 244 
filter sterilised batch culture fermentation supernatants of the simulated digestion of açai , or 245 
with the açai  free fermentation as a control (2.5%,250µl) for 24 hours at 37˚C. After 24 hours 246 
cells were trypsinised and resuspended in media where they were challenged with 75mM 247 
H2O2 (100µl) (Sigma-Aldrich, UK) on ice (4˚C) for 5 minutes. Cell viability was assessed 248 
before and after incubation using Trypan blue.  The cells were then centrifuged for 5 249 
minutes at 250 g at 4˚C, and the supernatant discarded. The cells were re-suspended in 85µl 250 
of 0.85% lower melting agarose (Sigma-Aldrich, UK) in PBS and maintained in a water bath 251 
at 43˚C. The suspension was mixed well and coated onto frosted slides (pre coated with a 252 
layer of 1% normal melting point agarose) (Sigma- Aldrich, UK).  The slides were incubated 253 
at 4 oC for 10 minutes before being placed in cell lysis buffer (1% Triton X-100 2.5 NaCl, 254 
0.1M EDTA, 0.01M Tris at pH10) for 1 hour at 4˚C. The slides were washed with 100 ml of 255 
enzyme buffer pH 8.0 (400 mM Hepes, 1M KCL, 5mM EDTA, 2mg/ml BSA Sigma-Aldrich, 256 
UK) in a staining jar three times for 5 minutes at 4˚C. For base specific assessment of 257 
oxidised pyrimidines or purines we applied a (100 µl) treatment of either Endonuclease III 258 
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(10,000 units/ml) (EndoIII) or Formamidopyrimidine-DNA   glycosylase (8,000 units/ml) 259 
(FPG) respectively to a subset of the slides post-treatment; control slides were exposed to 260 
enzyme reaction buffer, in the absence of enzymes. The enzyme treated slides were incubated 261 
at 37˚C for 45 min with the EndoIII or 30 min with the FPG treatment. The DNA was 262 
allowed to unwind in electrophoresis buffer (10M NaOH, 0.2M EDTA, pH 13.5, Sigma-263 
Aldrich, UK) at 4˚C for 20 minutes before electrophoresis (20 minutes at 26V, 300 MA 264 
(0.037 V/cm). After that, the slides were washed 3 times with neutralising buffer (0.4M Tris, 265 
pH 7.5 with HCl, Sigma-Aldrich, UK) at 4˚C for 5 minutes. All slides were stained with 45µl 266 
of ethidium bromide (20µg/ml in PBS) and stored in a dark, moist box at 4˚C for no longer 267 
than 48h. Comets were visualised at 400 X magnification using an epifluorescence microscope 268 
(Olympus, Bx51). Fifty cells per slide were analysed and the % tail moments quantified using 269 
Komet 5.5 image analysis software (Kinetic Imaging Ltd, Liverpool, UK). The mean was 270 
calculated for 50 cells from each slide (with each sample in triplicate) and the data were 271 
presented as mean % tail DNA compared to controls (McCann et al., 2007).  272 
2.13    Statistical analysis 273 
All statistical analysis was completed using the software PASW18 (SPSS).The microbial 274 
counts and profiles of the feacal samples from the three donors were different at baseline, as 275 
a result mean changes from baseline in the bacterial populations, following fermentation are 276 
reported. Comparisons of each microbial phyla response to treatment or control after 277 
fermentation were made using independent samples T-tests. A one-way analysis of variance 278 
(ANOVA) with a Tukey post-hoc test was conducted to evaluate the changes in microbial 279 
populations with time (0, 8 and 24 hours). The short chain fatty acid data were analysed 280 
using the same approach. An independent samples t-test was used to evaluate comet assay 281 
data. (*P<0.05, **P<0.01, *** P<0.001).282 
 283 
 284 
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3 Results 285 
3.1 Changes in bacterial populations with in vitro batch culture fermentation.  286 
Fluorescence in situ hybridisation was used to assess changes in microbial populations 287 
following batch fermentation of colonic samples at 0, 8 and 24h of fermentation. The 288 
three faecal donors exhibited marked differences in microbial composition at time point 289 
zero, and data are therefore expressed in terms of changes from baseline of specific 290 
phylum following fermentation. The specific effects of fermentation broth enriched with 291 
the digesta from the açai are compared with açai digesta free fermentations. No significant 292 
differences were observed in total bacteria in the fermentations containing the acai digesta 293 
compared to control (Eub338). The inclusion of digested açai pulp inhibited the growth of 294 
Clostridium histolyticum group (Chis150) at 8h (with a log -0.19 ±0.10 reduction in 295 
bacterial counts from baseline with digested acai, not observed in the control (P<0.05)) 296 
and at 24h (with a log -0.24 ± 0.07 reduction in bacterial counts from baseline with 297 
digested acai, also not observed in the control (P<0.05)) (Figure 1). Bacteroides-298 
Prevotella spp. (Bac303) counts were also reduced following the inclusion of digested 299 
açai pulp in the fermentation broth at both 8 h (reduction in counts from baseline by log -300 
0.14 ±0.11, not observed in the control (P<0.05)) and at 24 h (with a reduction in cell 301 
counts from baseline of log -0.09 ±0.07) not observed for the negative control (P<0.05)) 302 
Figure 1. At the phylum level, no significant differences were observed for the 303 
Bifidobacterium spp., the Lactobacillus/Enterococcus spp., or the Clostridium-coccoides 304 
Eubacterium rectale group  305 
3.2     Short-chain fatty acid production. 306 
The short-chain fatty acid (SCFA) concentrations of the supernatants produced during 307 
fermentation were analysed by High Performance Liquid Chromatography (HPLC). 308 
SCFA concentrations in the batch culture at 8h and 24h of fermentation for açai pulp and 309 
negative control are shown in Figure 2. Inclusion of digested açai pulp in the 310 
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fermentation broth resulted in increased concentrations of total SCFA and of acetic acid at 311 
8 and 24 hours (P<0.001), propionic acid at 24 hours (P<0.01) and butyric acid at 24 312 
hours (P<0.05) relative to control Figure 2. 313 
3.3 Degradation of polyphenols during digestion and fermentation by human faecal 314 
bacteria and their antioxidant capacity. 315 
Major phenolic compounds present in açai were identified by HPLC, samples were taken 316 
through the simulated digestion model to follow the degradation of these compounds prior to 317 
batch culture fermentation (Table 1). The main phenolic compounds present in açai pulp 318 
prior to the digestion were p-hidroxybenzoic acid followed by gentisic acid, chlorogenic acid, 319 
caffeic acid, syringic acid, ferulic acid, trans-cinnamic acid, quercetin and vanillic acid,  320 
cyanidin-3-O-glucoside cyanidin-3-O-rutinoside, pelargonidin-3-O-glucoside and peonidin-321 
3-O-rutinoside. All of these were still present following the simulated gastric digestion. 322 
However, after the intestinal digestion, considerable degradation of specific polyphenols had 323 
occurred with the anthocyanin concentration decreasing markedly compared to the original 324 
açai pulp. After dialysis peonidin-3-O-rutinoside was not detected. Following the dialysis 325 
process gentisic acid, chlorogenic acid, caffeic acid, syringic acid, ferulic acid, trans-326 
cinnamic acid and  quercetin were recovered albeit in concentrations markedly reduced from 327 
those observed with the raw açai. As measured by the folin ciocalteau assay the availability 328 
of total phenolics had reduced by 51% following the digestion of the açai pulp (Table 1). 329 
Following dialysis, the digested açai was added to fermentation media and fermented in 330 
batch cultures using human faecal samples as innocula, samples of the fermentation 331 
supernatant were collected at 0, 8 and 24h analysed using HPLC for individual phenolics 332 
(Table 2) and for total phenolics via Folin Ciocalteau. After 24 hours of fermentation, 7 333 
polyphenols were recovered, p-hidroxybenzoic acid, chlorogenic acid,  ferulic acid, quercetin 334 
acid, and vanillin acid. Their concentrations decreased progressively with incubation time. No 335 
phenolic compounds were detected in the control samples (standard fermentation broth).  336 
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Undigested açai, with its very high anthocayanin content had considerable antioxidant 337 
capacity as observed in the FRAP assay. With the simulated digestion and destruction of 338 
polyphenols the antioxidant capacity fell by 57% and following fermentation the total 339 
antioxidant capacity was 34% of that of the undigested açai. Batch culture fermentation 340 
supernatants with the digested açai did however have a higher total antioxidant capacity than 341 
the control fermentation supernatant (Table 2). Sugar and dietary fibre were analysed by 342 
Campden BRI laboratories (AOAC Method AC-203). The açai pulp total fibre content was 343 
15.5 g/100 g (15.0g/100 insoluble) and 1.6 g /100 g of sugar.  After the digestion the açai 344 
pulp had a remaining total fibre content of 10.2 g/ 100g and a sugar content of 1.0g /100g. 345 
3.4 Cytotoxicity of fermented açai digests. 346 
HT29 cells were treated with filter sterilised fermentation supernatants at a concentration of 347 
0%, 1%, 2.5%, 5% and 10% (v/v) in carrier control media for 24 hours. There were no 348 
cytotoxic effects after 24 hours for either the açai or the carrier control fermentations at 349 
concentrations of 1% and 2.5% v/v. However, at 5% and 10% concnetrations, viability fell 350 
to 80% and to 56% respectively. The 2.5% v/v dilution was therefore considered to be most 351 
appropriate for further investigation (Supplemental Figure 1).   352 
3.5 Anti-genotoxicity (Comet assay) 353 
The comet assay (Single Cell Gel Electrophoresis) was used to assess DNA damage. Filter 354 
sterilised samples were prepared from the fermentation broths, collected at 0 hours of 355 
fermentation, or following 24 hours of fermentation. These supernatants were applied at 356 
2.5% v/v in carrier control to HT-29 cells and incubated for 24 hours, DNA damage was then 357 
induced by subsequent exposure to 75 𝜇M H2O2 for 5 minutes. A significant anti-genotoxic 358 
effect (P<0.05) was observed for the fermentation supernatant containing the digested açai at 359 
0 hours, with a reduction in DNA damage of approximately 31.5% (6.66 ± 1.2 %) verses the 360 
açai free fermentation supernatant used as a negative control (9.73 ± 0.8 % tail DNA) (Figure 361 
3). Moreover, after 24h incubation the fermentation supernatant from the açai digesta 362 
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conferred protection against oxidised purines in the FPG modified assay (10.27 ± 0.5 % vs 13 363 
± 0.2 % tail DNA) (P<0.05) Figure 3. 364 
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4 Discussion. 365 
Here, we present data modelling the effects of consuming of açai on the gastrointestinal 366 
tract. In the first instance, our work demonstrates that polyphenols present in açai may be 367 
degraded during the digestion process, but importantly, that they are not fully destroyed and 368 
a significant percentage of these compounds may therefore reach the colon. In our simulated 369 
colonic environment, these phenolics were shown to be further degraded, and alongside the 370 
dietary fibre present in açai, they may influence the composition of the gut microbiota, with 371 
resultant increases in the synthesis of SCFA. Finally, the presence of digested açai in the 372 
fermentative model of the colon is shown to confer protection against genotoxic insult in 373 
what is an otherwise carcinogenic environment.    374 
Food ingredients escaping digestion in the upper GI tract, which then go on to selectively 375 
stimulate the growth and activities of beneficial gut microflora, such as bifidobacteria and 376 
lactobacilli, over less desirable groups, such as Clostridium histolyticum, may be considered 377 
prebiotic (Gibson, 1998). We used a 24h pH-controlled batch-culture fermentation model, 378 
inoculated with human faecal microbiota, to examine the prebiotic potential of digested açai 379 
pulp. We found an inhibition in the growth of Bacteroides-Prevotella and Clostridium 380 
histolyticum when digested açai was incorporated into culture media. Bacteroides are a 381 
dominant species in the gut, and whilst largely symbiotic and sacchorolytic, they can be 382 
opportunistic pathogens (Sánchez-Patán et al., 2012). In contrast, within the Clostridium 383 
histolyticum group there are some well-studied pathogens, such as Clostridium perfringens, 384 
as such, a reduction in this microbial group is considered to be a positive modulation of the 385 
microbiota. The reduction in the observed relative counts of Bacteroides-Prevotella and 386 
Clostridium histolyticum with the digested açai may result from the availability of substrate 387 
which is preferentially utilised by other bacterial groups, alternatively polyphenols in the 388 
culture media may be selectively inhibiting microbial growth (Tzounis et al., 2008). Phenolic 389 
compounds and their metabolites have previously been shown to inhibit the growth of 390 
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harmful bacteria (Cueva et al., 2013), although further work is need to understand our 391 
observation.  392 
The production of SCFA, as a result of saccharolytic fermentation, in the large intestine is 393 
also of benefit to the health of the host (Collins & Gibson, 1999). SCFAs serve as substrates 394 
for energy metabolism in the colonic epithelia (Gibson, 1998), they may also reduce the 395 
growth of pathogens, exert anti-cancer and anti-inflammatory activities, and they serve as 396 
signalling molecules in the gut-brain axis, influencing metabolism  and satiety (Gibson, 397 
Probert, Van Loo, Rastall, & Roberfroid, 2004). In this study, the total SCFA, and the acetic 398 
acid, propionate and butyrate concentrations were all higher in supernatants from the 399 
fermentations with the digested açai pulp. Acetic acid is the main product of saccharolytic 400 
fermentation by bifidobacteria and bacteroides (Collins & Gibson, 1999). As our bacteriodes 401 
count decreased with the digested açai, and there were no significant differences between the 402 
numbers of bifidobacteria in treatment versus control, the observed higher concentrations of 403 
acetate may reflect the utilization of lactic acid by other microorganisms, thus producing 404 
acetate via cross feeding (Hernandez-Hernandez, Côté, Kolida, Rastall, & Sanz, 2011).  405 
Polyphenols present in açai are credited with the high anti-oxidant capacity of this food 406 
(Pacheco-palencia, Hawken, & Talcott, 2007). We recently completed an acute human 407 
dietary intervention study with acai, in which we observed reduced total plasma oxidant 408 
capacity following acai consumption (Alqurashi et al., 2016). This is consistent with the 409 
recent findings of Pala et al. also suggesting that acai phenolics or their metabolites are 410 
bioavailable in vivo (Pala et al., 2017). Henning et al. have shown that açai retains its anti-411 
oxidant capacity post in vitro digestion (Henning et al., 2014). However, to our knowledge, 412 
ours is the first study to investigate the fate of açai polyphenols during the processes of both 413 
digestion and fermentation in a model of the intestinal tract. Notably, we report that the anti-414 
oxidant capacity may be retained in the colon following interaction with the microbiome. 415 
This observation was of particular interest; in our previous human dietary intervention study, 416 
we observed spikes in improvements in arterial function at 2 hours and again at 6 hours post 417 
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ingestion of acai, strongly suggesting the liberation of bioactives from ingested acai in the 418 
colon (Alqurashi et al., 2016). The quenching of oxidative stress in the gut prevents DNA 419 
damage in colonic epithelia, and thus may protect against cancer at that site, and our previous 420 
human intervention trial suggests benefits to vascular health from acai as a consequence of 421 
gut microbial function.        422 
During the intestinal digestion ~50% of the total phenolic compounds were destroyed with 423 
considerable biotransformation and degradation of individual phenolics. The resistance of 424 
phenolics to digestion is understood to be related to structural sensitivity to enzymes and 425 
acid. We observed survival of some of the anthocyanins as far as the batch culture 426 
fermentation phase of the model; however no anthocyanins were recovered post 427 
fermentation. Anthocyanins are hydrolysed by the intestinal microbiota to small phenolic 428 
acids which may be absorbed in to the blood stream where they seemingly influence health 429 
(Keppler & Humpf, 2005) (Vitaglione et al., 2007).  430 
Having identified an increased antioxidant capacity, and higher levels of phenolics, and of 431 
SCFA in the gut model fermentation supernatants, we were interested in potential anticancer 432 
activity. The COMET assay is a widely used, semi-quantitative measure of DNA damage 433 
which is considered an early event in the cancer process.  In the colonic HT29 cell line, 434 
exposure to our filter-sterilised batch-culture fermentation products inhibited peroxide 435 
induced DNA damage. The colonic environment in man is carcinogenic (Sánchez-Patán et 436 
al., 2012), dietary exposures which attenuate latent genotoxicity in the colon are therefore 437 
desirable. Dietary intervention studies with both polyphenol, and with dietary fibre, rich 438 
foods lead to lower faecal sample genotoxicity as assessed against HT29 cells in the comet 439 
assay (Eid et al., 2015). A similar dietary intervention study with açai is needed to confirm 440 
that this may be of benefit to the consumer.    441 
Our study utilizes an in vitro model to mimic gastrointestinal transformations which are 442 
otherwise challenging to capture in vivo.  These models have been widely used and are well 443 
published. The batch culture fermentation system has been developed to screen the effects of  444 
19 
 
foods and nutrients on human colon microbiota (Salminen et al., 1998). However, as a model 445 
it simulates only the conditions of the distal colon, with pH control mimicking conditions at 446 
that site but limiting the success of species which thrive at lower pH  (Faber, Fahey Jr, 447 
Paeschke, & Aimutis, 2011). Furthermore, there is no clearance of substrate/and or 448 
fermentation products via the absorptive process, as would occur in vivo; the build-up of 449 
product in the fermentation vessel affects microbial activity and metabolite production. 450 
However this work provides insight into mechanisms through which açai consumption might 451 
influence both digestive and systemic health, and provides evidence to justify further 452 
intervention.453 
20 
 
5 Acknowledgement 454 
We thank the Saudi Arabian Ministry of Education for funding this study. We also like to 455 
thank Sublimefood (UK) for the açai berries used on the study.  456 
 457 
 458 
 459 
 460 
 461 
 462 
 463 
 464 
 465 
 466 
 467 
 468 
 469 
 470 
 471 
 472 
 473 
 474 
 475 
 476 
 477 
 478 
 479 
21 
 
6 References.  480 
Arts, I. C., & Hollman, P. C. (2005). Polyphenols and disease risk in epidemiologic studies. The 481 
American journal of clinical nutrition, 81(1), 317S-325S.  482 
Benzie, I. F., & Strain, J. (1996). The ferric reducing ability of plasma (FRAP) as a measure of 483 
“antioxidant power”: the FRAP assay. Analytical biochemistry, 239(1), 70-76.  484 
Brown, E. M., McDougall, G. J., Stewart, D., Pereira-Caro, G., Gonzalez-Barrio, R., Allsopp, P., Magee, 485 
P., Crozier, A., Rowland, I., Gill, C. I. (2012). Persistence of anticancer activity in berry extracts 486 
after simulated gastrointestinal digestion and colonic fermentation. PloS one, 7(11), e49740. 487 
doi: 10.1371/journal.pone.0049740 488 
Coates, E. M., Popa, G., Gill, C. I., McCann, M. J., McDougall, G. J., Stewart, D., & Rowland, I. (2007). 489 
Colon-available raspberry polyphenols exhibit anti-cancer effects on in vitro models of colon 490 
cancer. Journal Carcinog, 6, 4. doi: 10.1186/1477-3163-6-4 491 
Collins, M. D., & Gibson, G. R. (1999). Probiotics, prebiotics, and synbiotics: approaches for 492 
modulating the microbial ecology of the gut. The American journal of clinical nutrition, 69(5), 493 
1052s-1057s.  494 
Cueva, C., Sánchez-Patán, F., Monagas, M., Walton, G. E., Gibson, G. R., Martín-Álvarez, P. J., 495 
Bartolome, B., Moreno-Arribas, M. V. (2013). In vitro fermentation of grape seed flavan-3-ol 496 
fractions by human faecal microbiota: changes in microbial groups and phenolic metabolites. 497 
FEMS microbiology ecology, 83(3), 792-805.  498 
Daims, H., Brühl, A., Amann, R., Schleifer, K.-H., & Wagner, M. (1999). The domain-specific probe 499 
EUB338 is insufficient for the detection of all Bacteria: development and evaluation of a 500 
more comprehensive probe set. Systematic and applied microbiology, 22(3), 434-444.  501 
Daims, H., Stoecker, K., & Wagner, M. (2005). Fluorescence in situ hybridization for the detection of 502 
prokaryotes. Molecular microbial ecology, 213, 239.  503 
Del Pozo-Insfran, D., Brenes, C. H., & Talcott, S. T. (2004). Phytochemical composition and pigment 504 
stability of Açai (Euterpe oleracea Mart.). Journal of agricultural and food chemistry, 52(6), 505 
1539-1545.  506 
Eid, N., Osmanova, H., Natchez, C., Walton, G., Costabile, A., Gibson, G., Rowland, I., Spencer, J. P. 507 
(2015). Impact of palm date consumption on microbiota growth and large intestinal health: a 508 
randomised, controlled, cross-over, human intervention study. British Journal of Nutrition, 509 
114(08), 1226-1236.  510 
Faber, T. A., Fahey Jr, G. C., Paeschke, T., & Aimutis, W. (2011). Animal, in vitro, and cell culture 511 
models to study the role of dietary fibers in the gastrointestinal tract of humans. 512 
Nondigestible carbohydrates and digestive health, 97-123.  513 
Franks, A. H., Harmsen, H. J., Raangs, G. C., Jansen, G. J., Schut, F., & Welling, G. W. (1998). Variations 514 
of bacterial populations in human feces measured by fluorescent in situ hybridization with 515 
group-specific 16S rRNA-targeted oligonucleotide probes. Applied and environmental 516 
microbiology, 64(9), 3336-3345.  517 
Gaezon, G.A., Narvaez-Cuenca, C.E., Vincken, J.P., Gruppen, H. (2017). Polyphenolic composition and 518 
antioxidant activity of açai (Euterpe oleracea Mart.) from Colombia. Journal of Food 519 
Chemistry, 15;217: 364-72.  520 
Gibson, G. R. (1998). Dietary modulation of the human gut microflora using prebiotics. The British 521 
journal of nutrition, 80(4), S209-212.  522 
Gibson, G. R., Probert, H. M., Van Loo, J., Rastall, R. A., & Roberfroid, M. B. (2004). Dietary 523 
modulation of the human colonic microbiota: updating the concept of prebiotics. Nutrition 524 
Research Reviews, 17(2), 259-275.  525 
Gordon, A., Cruz, A. P. G., Cabral, L. M. C., de Freitas, S. C., Taxi, C. M. A. D., Donangelo, C. M., 526 
Mattietto, R. A., Marx, F. (2012). Chemical characterization and evaluation of antioxidant 527 
properties of Açaí fruits (Euterpe oleraceae Mart.) during ripening. Food chemistry, 133(2), 528 
256-263. doi: 10.1016/ Journal of Food Chemistry 2011.11.150 529 
 530 
Guergoletto, K. B., Costabile, A., Flores, G., Garcia, S., & Gibson, G. R. (2016). In vitro fermentation of 531 
juçara pulp (Euterpe edulis) by human colonic microbiota. Food chemistry, 196, 251-258.  532 
22 
 
Harmsen, H. J., Elfferich, P., Schut, F., & Welling, G. W. (1999). A 16S rRNA-targeted probe for 533 
detection of lactobacilli and enterococci in faecal samples by fluorescent in situ hybridization. 534 
Microbial Ecology in Health and Disease, 11(1), 3-12.  535 
Heinrich, M., Dhanji, T., & Casselman, I. (2011). Açai (Euterpe oleracea Mart.)—A phytochemical and 536 
pharmacological assessment of the species’ health claims. Phytochemistry Letters, 4(1), 10-537 
21. doi: 10.1016/j.phytol.2010.11.005 538 
Henning, S. M., Zhang, Y., Rontoyanni, V. G., Huang, J., Lee, R.-P., Trang, A., . . . Heber, D. (2014). 539 
Variability in the antioxidant activity of dietary supplements from pomegranate, milk thistle, 540 
green tea, grape seed, goji, and acai: Effects of in vitro digestion. Journal of agricultural and 541 
food chemistry, 62(19), 4313-4321.  542 
Hernandez-Hernandez, O., Côté, G. L., Kolida, S., Rastall, R. A., & Sanz, M. L. (2011). In vitro 543 
fermentation of alternansucrase raffinose-derived oligosaccharides by human gut bacteria. 544 
Journal of agricultural and food chemistry, 59(20), 10901-10906.  545 
Keppler, K., & Humpf, H.-U. (2005). Metabolism of anthocyanins and their phenolic degradation 546 
products by the intestinal microflora. Bioorganic & medicinal chemistry, 13(17), 5195-5205.  547 
Langendijk, P. S., Schut, F., Jansen, G. J., Raangs, G. C., Kamphuis, G. R., Wilkinson, M., & Welling, G. 548 
W. (1995). Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-549 
specific 16S rRNA-targeted probes and its application in fecal samples. Applied and 550 
environmental microbiology, 61(8), 3069-3075.  551 
Lima Yamaguchi, K.K., Ravazi Pereira, L.F., Lamarão, C.V., Lima, E.S., Veiga-Junior, V.F.(2015). Amazon 552 
acai: Chemistry and biological activities: A review. Journal of Food Chemistry,179 (2015) 137-553 
151.  554 
 555 
Maccaferri, S., Klinder, A., Cacciatore, S., Chitarrari, R., Honda, H., Luchinat, C., Brigidi, P., Carnevali, 556 
P., Gibson, G.R., Brigidi,P., Castabile, A. (2012). In vitro fermentation of potential prebiotic 557 
flours from natural sources: impact on the human colonic microbiota and metabolome. 558 
Molecular nutrition & food research, 56(8), 1342-1352.  559 
Manz, W., Amann, R., Ludwig, W., Vancanneyt, M., & Schleifer, K.-H. (1996). Application of a suite of 560 
16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum 561 
cytophaga-flavobacter-bacteroides in the natural environment. Microbiology, 142(5), 1097-562 
1106.  563 
Marchesi, J. R., Adams, D. H., Fava, F., Hermes, G. D., Hirschfield, G. M., Hold, G., Quraishi, M., 564 
Kinross, J., Smidt, H., Tuohy, K. M., Thomas, L.V., Zoetendal, E.G., Hart, A. (2016). The gut 565 
microbiota and host health: a new clinical frontier. Gut, 65(2), 330-339.  566 
McCann, M., Gill, C., O’Brien, G., Rao, J., McRoberts, W., Hughes, P., McEntee, R.,  Rowland, I. (2007). 567 
Anti-cancer properties of phenolics from apple waste on colon carcinogenesis in vitro. Food 568 
and Chemical Toxicology, 45(7), 1224-1230.  569 
Mills, D., Tuohy, K., Booth, J., Buck, M., Crabbe, M., Gibson, G., & Ames, J. (2008). Dietary glycated 570 
protein modulates the colonic microbiota towards a more detrimental composition in 571 
ulcerative colitis patients and non‐ulcerative colitis subjects. Journal of applied microbiology, 572 
105(3), 706-714.  573 
 574 
Pacheco-palencia, L. A., Hawken, P., & Talcott, S. T. (2007). Phytochemical, antioxidant and pigment 575 
stability of açai (Euterpe oleracea Mart.) as affected by clarification, ascorbic acid 576 
fortification and storage. Food research international, 40(5), 620-628.  577 
Ramnani, P., Chitarrari, R., Tuohy, K., Grant, J., Hotchkiss, S., Philp, K., Campbell, R., Rowland, I. 578 
(2012). In vitro fermentation and prebiotic potential of novel low molecular weight 579 
polysaccharides derived from agar and alginate seaweeds. Anaerobe, 18(1), 1-6. doi: 580 
10.1016/j.anaerobe.2011.08.003 581 
Rodriguez-Mateos, A., Cifuentes-Gomez, T., Tabatabaee, S., Lecras, C., & Spencer, J. P. (2012). 582 
Procyanidin, anthocyanin, and chlorogenic acid contents of highbush and lowbush 583 
blueberries. Journal of agricultural and food chemistry, 60(23), 5772-5778.  584 
Rodriguez-Mateos, A., Rendeiro, C., Bergillos-Meca, T., Tabatabaee, S., George, T. W., Heiss, C., & 585 
Spencer, J. P. (2013). Intake and time dependence of blueberry flavonoid–induced 586 
improvements in vascular function: a randomized, controlled, double-blind, crossover 587 
23 
 
intervention study with mechanistic insights into biological activity. The American journal of 588 
clinical nutrition, 98(5), 1179-1191.  589 
Salminen, S., Bouley, C., Boutron, M.-C., Cummings, J., Franck, A., Gibson, G., Isolauri, E., Moreau, M., 590 
Roberfroid, M., Rowland, I. (1998). Functional food science and gastrointestinal physiology 591 
and function. British Journal of Nutrition, 80(S1), S147-S171.  592 
Sánchez-Patán, F., Cueva, C., Monagas, M., Walton, G. E., Gibson M, G. R., Quintanilla-López, J. s. E., . 593 
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7  Figure Captions.  633 
Figure 1.  634 
Change from baseline in bacterial phyla as analysed by fluorescence in situ hybridisation 635 
(FISH) in a batch culture fermentation containing digested açai fruit or a negative control at 8 636 
and 24 h of fermentation. Results are reported as the mean of three independent fermentations 637 
with faecal samples from three different donors used as inoculate (n = 3) in log 10 CFU/ml ± 638 
standard deviations (SD). Significant differences between treatment and control fermentation 639 
are reported using a t-test *P<0·05, **P<0·01). 640 
Figure 2. Mean change in concentration from baseline for the Short chain fatty acids 641 
produced during the fermentation of pre-digested açai fruit or a negative control in a pH- 642 
controlled batch culture with faecal inoculate. Results are reported as the mean of three 643 
independent fermentations with faecal samples from three different donors used as inoculate 644 
(n = 3). Significant differences between treatment and control fermentation are reported 645 
using a t-test (using t-test, ***P<0.001, **P<0·01 *P<0·05). 646 
Figure 3. The anti-genotoxic effects of fermentation supernatants containing digested açai or 647 
a negative control (acai free digesta fermentation) on HT-29 cells (COMET assay). HT-29 648 
cells were incubated with filter sterilized mixed-culture fermentation supernatants (sampled 649 
at 0h & 24h of the fermentation) for 24h before challenge with H202 (75µM for 5 min). Data 650 
representing mean % tail DNA, from three experimental runs involving different feacal 651 
innocula donors. The buffer only treatment represents global DNA damage, The EndoIII 652 
enzyme was used to assess oxidised pyrimidines. The FPG enzyme was used to assess 653 
oxidised purines. (*= p<0.05 independent sample T-test). 654 
Supplemental Figure 1. Cytotoxicity of fermentation supernatants containing acai 655 
presented as mean ± SD percent cell viability of HT-29 cells (n=3). HT-29 cells 656 
were incubated with filter sterilised supernatant sampled at 0h (A) and at 24 hours 657 
(B) of the fermentation. The percentage of cells surviving the treatment was 658 
determined by DAPI staining. 659 
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